Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Ortho Clinical Diagnostics Holdings Plc (OCDX) since 2021 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Ortho Clinical Diagnostics Holdings Plc. Table 2 shows the detailed insider transactions. This company's CIK number is 1828443.
Total stock buying since 2021: $0.
Total stock sales since 2021: $448,929,936.
Total stock option exercises since 2021: $4,060,451.
Insider Buying | Insider Sales | Option Exercises | ||||
---|---|---|---|---|---|---|
Year | Shares | Value | Shares | Value | Shares | Value |
2022 | 0 | $0 | 318,043 | $6,503,584 | 318,043 | $2,625,310 |
2021 | 0 | $0 | 26,117,206 | $442,426,352 | 228,526 | $1,435,141 |
Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
---|---|---|---|---|---|---|
year-month | Shares | Value | Shares | Value | Shares | Value |
2022-04 | 0 | $0 | 88,043 | $1,652,214 | 88,043 | $552,910 |
2022-01 | 0 | $0 | 230,000 | $4,851,370 | 230,000 | $2,072,400 |
2021-10 | 0 | $0 | 75,464 | $1,488,980 | 75,464 | $473,913 |
2021-09 | 0 | $0 | 25,300,000 | $425,040,000 | 0 | $0 |
2021-08 | 0 | $0 | 741,742 | $15,897,372 | 153,062 | $961,228 |
Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2022-04-04 | Schlesinger Michael A. (EVP, GC and Secretary) | Sale | 88,043 | 18.77 | 1,652,214 |
2022-04-04 | Schlesinger Michael A. (EVP, GC and Secretary) | Option Ex | 88,043 | 6.28 | 552,910 |
2022-01-03 | Schlesinger Michael A. (EVP, GC and Secretary) | Sale | 130,000 | 21.09 | 2,741,570 |
2022-01-03 | Schlesinger Michael A. (EVP, GC and Secretary) | Option Ex | 130,000 | 6.28 | 816,400 |
2022-01-03 | Smith Christopher M (Chairman and CEO) | Sale | 100,000 | 21.10 | 2,109,800 |
2022-01-03 | Smith Christopher M (Chairman and CEO) | Option Ex | 100,000 | 12.56 | 1,256,000 |
2021-10-15 | Schlesinger Michael A. (EVP, GC and Secretary) | Sale | 75,464 | 19.73 | 1,488,980 |
2021-10-15 | Schlesinger Michael A. (EVP, GC and Secretary) | Option Ex | 75,464 | 6.28 | 473,913 |
2021-09-14 | Carlyle Partners Vi Cayman Holdings, L.p. (10% Owner) | Sale | 25,300,000 | 16.80 | 425,040,000 |
2021-08-18 | Schlesinger Michael A. (EVP, GC and Secretary) | Sale | 41,015 | 20.14 | 826,001 |
2021-08-18 | Schlesinger Michael A. (EVP, GC and Secretary) | Option Ex | 41,015 | 6.28 | 257,574 |
2021-08-16 | Schlesinger Michael A. (EVP, GC and Secretary) | Sale | 4,000 | 20.03 | 80,112 |
2021-08-16 | Schlesinger Michael A. (EVP, GC and Secretary) | Option Ex | 4,000 | 6.28 | 25,120 |
2021-08-13 | Schlesinger Michael A. (EVP, GC and Secretary) | Sale | 4,300 | 20.00 | 86,004 |
2021-08-13 | Schlesinger Michael A. (EVP, GC and Secretary) | Option Ex | 4,300 | 6.28 | 27,004 |
2021-08-12 | Schlesinger Michael A. (EVP, GC and Secretary) | Sale | 8,100 | 20.00 | 162,000 |
2021-08-12 | Schlesinger Michael A. (EVP, GC and Secretary) | Option Ex | 8,100 | 6.28 | 50,868 |
2021-08-11 | Schlesinger Michael A. (EVP, GC and Secretary) | Sale | 72,585 | 19.77 | 1,434,642 |
2021-08-11 | Schlesinger Michael A. (EVP, GC and Secretary) | Option Ex | 72,585 | 6.28 | 455,833 |
2021-08-04 | Yates Robert Clifton (Director) | Sale | 140,042 | 21.79 | 3,051,515 |
2021-08-04 | Smith Christopher M (Chairman and CEO) | Sale | 61,800 | 21.79 | 1,346,622 |
2021-08-03 | Yates Robert Clifton (Director) | Sale | 176,149 | 21.59 | 3,803,056 |
2021-08-03 | Smith Christopher M (Chairman and CEO) | Sale | 104,987 | 21.55 | 2,262,784 |
2021-08-02 | Yates Robert Clifton (Director) | Sale | 25,551 | 22.06 | 563,629 |
2021-08-02 | Yates Robert Clifton (Director) | Option Ex | 23,062 | 6.28 | 144,829 |
2021-08-02 | Smith Christopher M (Chairman and CEO) | Sale | 103,213 | 22.10 | 2,281,007 |
Insider trading activities including stock purchases, stock sales, and option exercises of OCDX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Ortho Clinical Diagnostics Holdings Plc (symbol OCDX, CIK number 1828443) see the Securities and Exchange Commission (SEC) website.